Krishna C. Bulusu
AstraZeneca (United Kingdom)(GB)Gas Turbine Research Establishment(IN)Aquincum Institute of Technology(HU)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Biosimilars and Bioanalytical Methods, HER2/EGFR in Cancer Research
Most-Cited Works
- → DeepSynergy: predicting anti-cancer drug synergy with Deep Learning(2017)651 cited
- → Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen(2019)354 cited
- → Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives(2015)207 cited
- → Development of a Novel Azaspirane That Targets the Janus Kinase-Signal Transducer and Activator of Transcription (STAT) Pathway in Hepatocellular Carcinoma in Vitro and in Vivo(2014)159 cited
- → Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial(2023)159 cited
- → Knowledge graph-based recommendation framework identifies drivers of resistance in EGFR mutant non-small cell lung cancer(2022)90 cited